Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Patent: RE37314

« Back to Dashboard

Patent RE37314 protects CRESTOR and is included in one NDA. There has been one Paragraph IV challenge on Crestor. There are nine tentative approvals for the compound protected by this patent. Additional details are available via the generic ingredient links below.

Protection for CRESTOR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: RE37314

Title: Pyrimidine derivatives
Abstract:The compounds of the present invention inhibit the HMG-CoA reductase, and subsequently suppress the biosynthesis of cholesterol. And they are useful in the treatment of hypercholesterolemia, hyperlipoproteinemia, and atherosclerosis.
Inventor(s): Hirai; Kentaro (Kyoto, JP), Ishiba; Teruyuki (Osaka, JP), Koike; Haruo (Kyoto, JP), Watanabe; Masamichi (Shiga, JP)
Assignee: Shionogi Seiyaku Kabushiki Kaisha (Osaka, JP)
Application Number:09/141,731
Patent Claim Types:
see list of patent claims
Compound; Composition;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Ipr
CRESTOR
rosuvastatin calcium
TABLET;ORAL021366Aug 12, 2003RXNoRE37314*PED<disabled>
Ipr
CRESTOR
rosuvastatin calcium
TABLET;ORAL021366Aug 12, 2003RXYesRE37314*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: RE37314

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan3-188015Jul 01, 1991

International Patent Family for Patent: RE37314

Country Document Number Publication Date
United States of America5260440Nov 09, 1993
Taiwan203044Apr 01, 1993
Portugal521471Apr 30, 2001
Netherlands300125Jul 01, 2003
Luxembourg91042Nov 24, 2003
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc